Authors: Swaisland, H Laight, A Stafford, L Jones, H Morris, C Dane, A Yates, R

Citation: H. Swaisland et al., Pharmacokinetics and tolerability of the orally active selective epidermalgrowth factor receptor tyrosine kinase inhibitor ZD1839 in healthy volunteers, CLIN PHARMA, 40(4), 2001, pp. 297-306